Dutasteride

🧮 Dose calculator

Benign prostatic hyperplasia (BPH) · Regimen source: FDA Avodart · 2.1FDA Avodart · 2.2

• • Do not open or chew (oropharyngeal irritation). Pregnant women or those who may become pregnant must not handle capsules (skin absorption). FDA Avodart · 2FDA Avodart · 16

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyContraindicated

  Label: contraindicated in pregnancy. FDA Avodart · 4

  “AVODART is contraindicated for use in: • Pregnancy.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Avodart · 8.2

  “Risk Summary AVODART is not indicated for use in women.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Avodart · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Avodart · 8.5

  “No overall differences in safety or efficacy were observed between these subjects and younger subjects.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Avodart · 8.3

  “Infertility Males: The effects of dutasteride 0.5 mg/day on semen characteristics were evaluated in normal volunteers aged 18 to 52 years (n = 27 dutasteride, n = 23 placebo) throughout 52 weeks of treatment and 24 weeks of post-treatment follow-up.”